ArticleBlood cancer journal2025

The number of additional high molecular risk mutations predicts outcome after hematopoietic stem cell transplantation in primary and secondary myelofibrosis.

Maria Chiara Finazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.